TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biobact AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
23
|
125 |
| Financial expenses |
1
|
7
|
7 |
| Earnings before taxes |
-11
|
436
|
-147 |
| EBITDA |
-17
|
-129
|
-129 |
| Total assets |
323
|
508
|
251 |
| Current assets |
197
|
508
|
99 |
| Current liabilities |
5
|
180
|
241 |
| Equity capital |
318
|
328
|
-117 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
2
|
4 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
98.5%
|
64.6%
|
-46.6% |
| Turnover per employee |
0
|
12
|
31 |
| Profit as a percentage of turnover |
1895.7%
|
-117.6% | |
| Return on assets (ROA) |
-3.1%
|
87.2%
|
-55.8% |
| Current ratio |
3940.0%
|
282.2%
|
41.1% |
| Return on equity (ROE) |
-3.5%
|
132.9%
|
125.6% |
| Change turnover |
-23
|
-92
|
-99 |
| Change turnover % |
-100%
|
-80%
|
-44% |
| Chg. No. of employees |
-1
|
-2
|
-1 |
| Chg. No. of employees % |
-50%
|
-50%
|
-20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.